Sangam: A Confluence of Knowledge Streams

12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients

Files in this item

Files Size Format View
j.1432-2277.2006.00414.x.pdf 516.1Kb application/pdf View/Open

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse